Evidence map›Paper›PMID 29026950›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2018

The prognostic value of

Harald Grut, Svein Dueland, Pål Dag Line, Mona Elisabeth Revheim

Registry-linked trialAbstract read
PubMed Publisher
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05186116 (Living Donor Liver Transplantation), which is not on this map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05186116 narecruitingnot on this mapstarted 2022, after this paper: background citation

Living Donor Liver Transplantation (LDLT) in Non Resectable Colo-rectal Cancer Liver Metastasis. The LIVERMORE Trial (LIVing Donor livEr tRansplant Modena cOloRectal mEtastasis) [Original Title in Italian: "Trapianto di Fegato da Donatore Vivente Per Metastasi Epatiche Non Resecabili da Adenocarcinoma Del Colon"]

TypeinterventionalSponsorAzienda Ospedaliero-Universitaria di ModenaRan2022 to 2032Enrolled25ConditionsColon Adenocarcinoma, Liver Metastasis Colon CancerArmsLiving donor liver transplant, Split liver transplant, RAPID, DDLT
3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 57 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Sex-related differences in survival based on [Transplant international : official journal of the European Society for Organ Transplantation · 2026
    Article
  5. Article
  6. Review
  7. The prognostic value of [Clinical physiology and functional imaging · 2025
    Article
  8. Article
  9. The role ofAnnals of nuclear medicine · 2023
    Review
  10. Review
  11. Article
  12. Article
  13. Volumetric parameters from [Journal of neuroendocrinology · 2022
    Observational
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Harald GrutDivision of Radiology and Nuclear Medicine, Oslo University Hospital, P.o.box 4950, Nydalen, 0424, Oslo, Norway. harald.grut@gmail.com.ORCID http://orcid.org/0000-0001-9271-8789
Svein DuelandDivision of Oncology, Oslo University Hospital, Oslo, Norway.
Pål Dag LineInstitute of Clinical Medicine, University of Oslo, Oslo, Norway.
Mona Elisabeth RevheimDivision of Radiology and Nuclear Medicine, Oslo University Hospital, P.o.box 4950, Nydalen, 0424, Oslo, Norway.
Oslo University Hospital · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe main objective of this study was to evaluate the prognostic value of volumetric and metabolic information derivied from F-18 fluorodeoxyglucose positron emission tomography (

methodsThe preoperative

resultsTwenty-three patients underwent LT in the SECA study. Total MTV and TLG under the cut-off values were significantly correlated to improved OS at three and five years (p = 0.027 and 0.026) and DFS (p = 0.01). One, three and five-year OS and DFS were not significantly related to SUV

conclusionTotal MTV and TLG from

Indexed as

Fluorodeoxyglucose F18Liver TransplantationPositron Emission Tomography Computed TomographyAdultColorectal NeoplasmsFemaleHumansLiver NeoplasmsMaleMiddle AgedPatient SelectionRetrospective StudiesFluorodeoxyglucose F1818F-FDG PET/CTColorectal cancerLiver metastasesLiver transplantation

Identifiers

PMID29026950
OpenAlexW2761190505

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.